235 related articles for article (PubMed ID: 18984474)
1. Fibrosis and cirrhosis reversibility - molecular mechanisms.
Gieling RG; Burt AD; Mann DA
Clin Liver Dis; 2008 Nov; 12(4):915-37, xi. PubMed ID: 18984474
[TBL] [Abstract][Full Text] [Related]
2. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis.
Elsharkawy AM; Oakley F; Mann DA
Apoptosis; 2005 Oct; 10(5):927-39. PubMed ID: 16151628
[TBL] [Abstract][Full Text] [Related]
3. Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic.
Muddu AK; Guha IN; Elsharkawy AM; Mann DA
Int J Biochem Cell Biol; 2007; 39(4):695-714. PubMed ID: 17110155
[TBL] [Abstract][Full Text] [Related]
4. Fibrosis and cirrhosis reversibility: clinical features and implications.
Pinzani M; Vizzutti F
Clin Liver Dis; 2008 Nov; 12(4):901-13, x. PubMed ID: 18984473
[TBL] [Abstract][Full Text] [Related]
5. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?
Gressner OA; Rizk MS; Kovalenko E; Weiskirchen R; Gressner AM
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1024-35. PubMed ID: 18505415
[TBL] [Abstract][Full Text] [Related]
6. Fibrosis in the liver: acute protection and chronic disease.
Lee Y; Friedman SL
Prog Mol Biol Transl Sci; 2010; 97():151-200. PubMed ID: 21074733
[TBL] [Abstract][Full Text] [Related]
7. Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario.
Parola M; Marra F; Pinzani M
Mol Aspects Med; 2008; 29(1-2):58-66. PubMed ID: 18022682
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutical targets for revert liver fibrosis].
García B L; Gálvez G J; Armendáriz B J
Rev Med Chil; 2007 Jun; 135(6):783-91. PubMed ID: 17728907
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
Friedman SL
Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):98-105. PubMed ID: 16265071
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.
Di Sabatino A; Jackson CL; Pickard KM; Buckley M; Rovedatti L; Leakey NA; Picariello L; Cazzola P; Monteleone G; Tonelli F; Corazza GR; MacDonald TT; Pender SL
Gut; 2009 Jun; 58(6):777-89. PubMed ID: 19201776
[TBL] [Abstract][Full Text] [Related]
12. Vascular deterioration in cirrhosis: the big picture.
Bosch J
J Clin Gastroenterol; 2007; 41 Suppl 3():S247-53. PubMed ID: 17975472
[TBL] [Abstract][Full Text] [Related]
13. [Liver fibrosis: pathophysiology, diagnosis and treatment].
Pár A; Pár G
Orv Hetil; 2005 Jan; 146(1):3-13. PubMed ID: 15715367
[TBL] [Abstract][Full Text] [Related]
14. Reversal of hepatic fibrosis -- fact or fantasy?
Friedman SL; Bansal MB
Hepatology; 2006 Feb; 43(2 Suppl 1):S82-8. PubMed ID: 16447275
[TBL] [Abstract][Full Text] [Related]
15. Hepatic fibrogenesis.
Guo J; Friedman SL
Semin Liver Dis; 2007 Nov; 27(4):413-26. PubMed ID: 17979077
[TBL] [Abstract][Full Text] [Related]
16. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.
Svegliati-Baroni G; De Minicis S; Marzioni M
Liver Int; 2008 Sep; 28(8):1052-64. PubMed ID: 18783548
[TBL] [Abstract][Full Text] [Related]
17. Review article: the reversibility of cirrhosis.
Sohrabpour AA; Mohamadnejad M; Malekzadeh R
Aliment Pharmacol Ther; 2012 Nov; 36(9):824-32. PubMed ID: 22966946
[TBL] [Abstract][Full Text] [Related]
18. Genesis of hepatic fibrosis and its biochemical markers.
Das SK; Vasudevan DM
Scand J Clin Lab Invest; 2008; 68(4):260-9. PubMed ID: 18609066
[TBL] [Abstract][Full Text] [Related]
19. Extracellular matrix mediates a molecular balance between vascular morphogenesis and regression.
Davis GE; Senger DR
Curr Opin Hematol; 2008 May; 15(3):197-203. PubMed ID: 18391785
[TBL] [Abstract][Full Text] [Related]
20. Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma.
Shiwen X; Leask A; Abraham DJ; Fonseca C
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():19-26. PubMed ID: 19335743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
